Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) are 2 well-defined
entities that diverge in their basic pathogenic mechanisms and clinical evolution but they …

Mantle cell lymphoma (MCL) is a mature B-cell neoplasm initially driven by CCND1
rearrangement with 2 molecular subtypes, conventional MCL (cMCL) and leukemic non …

Mantle cell lymphoma (MCL) is a distinctive lymphoma type generally characterized by the
presence of CCND1 translocation and overexpression of cyclin D1. MCL usually presents …

Currently, prediction of time to treatment failure (TTF) and overall survival (OS) in mantle cell
lymphoma (MCL) is based on the clinical factors included in the Mantle Cell Lymphoma …

Mantle cell lymphoma (MCL) is characterized by the t (11; 14)(q13; q32) translocation
resulting in overexpression of cyclin D1. However, a small subset of cyclin D1− MCL has …

Mantle cell lymphoma (MCL) is an aggressive B-cell malignancy, but some patients have a
very indolent evolution. This heterogeneous course is related, in part, to the different …

Mantle cell lymphoma (MCL) is a mature B-cell neoplasm with a heterogeneous clinical and
biological behavior. SOX11 oncogenic expression contributes to the aggressiveness of …

Sex-determining region Y-related high-mobility-group box transcription factor 11 (SOX11) is
an essential member of the SOX transcription factors and has been highlighted as an …

SOX11 is a relevant element in the pathogenesis of MCL and has been instrumental to
identify two distinct clinicobiological subtypes of this tumor. Further studies should clarify the …

A large variety of lymphoma types may develop as primary intestinal neoplasms in the small
intestines or, less often, in the colorectum. Among these are a few entities such as …